Against the " placebo effect" : A personal point of view

Complementary Therapies in Medicine

Volumn 21, Issue 2, 2013, Pages 125-130

  Moerman, Daniel E ^a  

^a UNIVERSITY OF MICHIGAN DEARBORN   (United States)

Author keywords

Inert treatment; Meaning; Meaning response; Placebo

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; ATROPINE; CITALOPRAM; DIAZEPAM; FLUOXETINE; IMIPRAMINE; MORPHINE; NALOXONE; NEFAZODONE; PAROXETINE; PLACEBO; PROGLUMIDE; PROPRANOLOL; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ANALGESIA; ARTICLE; CLINICAL EFFECTIVENESS; DEPRESSION; HUMAN; PAIN; PARKINSON DISEASE; PHYSICIAN ATTITUDE; PLACEBO EFFECT; PRESCRIPTION; PROFESSIONAL KNOWLEDGE; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

BIOMEDICAL RESEARCH; FEMALE; HUMANS; MALE; PAIN; PHYSICIANS; PLACEBO EFFECT; PLACEBOS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 84875087658     PISSN: 09652299     EISSN: 18736963     Source Type: Journal    
DOI: 10.1016/j.ctim.2013.01.005     Document Type: Article

References (18)

1. Branthwaite A., Cooper P. Analgesic effects of branding in treatment of headaches. British Medical Journal (Clinical Research Ed) 1981, 282:1576-1578.
2. Gracely R.H., Dubner R., Deeter W.R., Wolskee P.J. Clinicians' expectations influence placebo analgesia. Lancet 1985, 1:43.
3. Levine J.D., Gordon N.C., Fields H.L. The mechanism of placebo analgesia. Lancet 1978, 2:654-657.
4. Benedetti F. The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia. Pain 1996, 64:535-543.
5. Phillips D.P., Ruth T.E., Wagner L.M. Psychology and survival. Lancet 1993, 342:1142-1145.
6. Phillips D.P., Liu G.C., Kwok K., Jarvinen J.R., Zhang W., Abramson I.S. The Hound of the Baskervilles effect: natural experiment on the influence of psychological stress on timing of death. British Medical Journal 2001, 323:1443-1446.
7. Park L.C., Covi L. Nonblind placebo trial. Archives of General Psychiatry 1965, 12:336-345.
8. Kaptchuk T.J.F.E., Kelley J.M., Sanchez M.N., Kokkotou E., Singer J.P., Kowalczykowski M., et al. Placebos without deception: a randomized controlled trial in irritable bowel syndrome. PLoS One 2010, 5:e15591.
9. Kirsch I., Moore T.J., Scorboria A., Nicholls S.S. The Emperor's new drugs: an analysis of antidepressant mediction data submitted to the U.S. Food and Drug Administration. Prevention and Treatment 2002, 5. http://www.journals.apa.org/prevention/volume5/pre0050023a.html.
10. Walsh B.T., Seidman S.N., Sysko R., Gould M. Placebo response in studies of major depression: variable, substantial, and growing. Journal of the American Medical Association 2002, 287:1840-1847.
11. Goodman L.S., Gilman A. The pharmacological basis of therapeutics 1970, The Macmillian Company, New York. 4th ed.
12. de La Fuente-Fernandez R., Ruth T.J., Sossi V., Schulzer M., Calne D.B., Stoessl A.J. Expectation and dopamine release: mechanism of the placebo effect in parkinson's disease. Science 2001, 293:1164-1166.
13. Leuchter A.F., Cook I.A., Witte E.A., Morgan M., Abrams M. Changes in brain function of depressed subjects during treatment with placebo. American Journal of Psychiatry 2002, 159:122-129.
14. Amanzio M., Pollo A., Maggi G., Benedetti F. Response variability to analgesics: a role for non-specific activation of endogenous opioids. Pain 2001, 90:205-215.
15. Price D.D. Assessing placebo effects without placebo groups: an untapped possibility?. Pain 2001, 90:201-203.
16. Benedetti F., Maggi G., Lopiano L., Lanotte M., Rainero I., Vighetti S., et al. Open versus hidden medical treatments: the patient's knowledge about a therapy affects the therapy outcome. Prevention and Treatment 2003, 6:1a.
17. Moerman D.E. Meaning, medicine and the " placebo effect" 2002, Cambridge University Press, Cambridge.
18. Moerman D.E., Jonas W.B. Deconstructing the placebo effect and finding the meaning response. Annals of Internal Medicine 2002, 136:471-476.